Search for: "Pfizer Corporation" Results 741 - 760 of 818
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2024, 1:18 pm by Melissa Tremblay
Even under Pfizer, the McKesson court noted, “a defendant’s knowledge of his general legal obligations is not enough if he does not also know that his actions violate those obligations. [read post]
25 Apr 2012, 4:56 am by Rob Robinson
Follow @InfoGovernance   eDiscovery News Content and Considerations A Judge Orders Predictive Coding Over Plaintiff Objection – bit.ly/Ic9lx7 (Evan Koblentz) Admissibility of Scientific Literature in the Internet Age – bit.ly/Icah4k (Andrew Kaufman) Allergies, eDiscovery and Karma: Yes, The Rules Apply to Law Firms, Too – bit.ly/ILU3N4 (Dennis Kiker) ‘Briggs’ and Emerging Standards on Government eDiscovery Obligations – bit.ly/HYwzUI (Norman Simon… [read post]
20 Jun 2008, 8:07 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Associated Press – AP files seven DMCA takedowns against Drudge Retort blog over users linking to its stories: (The Trademark Blog), (Techdirt), (Out-Law), (Electronic Frontier Foundation), (IPKat), (The Trademark Blog), ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v… [read post]
5 Jul 2008, 11:05 am
: (Intellectual Property Watch), Why compulsory licenses are bad: a look at the sausage making process: (Techdirt) More on ACTA: (LawFont.com) Global - Trade Marks / Domain Names / Brands Brand Finance 500: the annual report on the world’s most valuable brands: (IP finance), Gretchen Olive’s ‘10 steps to an effective domain name policy’: (IPwar’s), ICANN approves GNSO proposals imposing financial penalty on registrars who engage in excessive domain… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
13 Jan 2023, 3:00 am by Jim Sedor
Now those allies are a hot commodity among corporate clients eager to make inroads with McCarthy, who is in lockstep with corporate America on economic policy but has chastised major companies for wading into social and political issues. [read post]
8 Dec 2016, 8:38 am by Keith Mallinson
I would like to introduce you to guest blogger Trevor Soames, a leading Brussels based antitrust lawyerwith extensive experience of major high tech and IP-related investigations and litigation, having represented several major corporations in various cases over the years including Qualcomm, Nokia, Samsung and Microsoft.The Competition Directorate of the European Commission (DG Comp) has, over the years, become increasingly interested and active in the field of SEPs. [read post]
30 Dec 2010, 1:01 pm by Frank Pasquale
Companies such as GlaxoSmithKline have restructured and slimmed down their research arms but the sector remains troubled, as the departure of Jeff Kindler, Pfizer’s former chief executive, on the grounds of “exhaustion” indicates.The obvious course with something that is not working is to drop it. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
5 Sep 2023, 12:16 pm by Bona Law PC
These include the Pfizer/Seagen or Biogen/Reata pending transactions, for instance. [read post]
19 Jan 2010, 10:15 am by Beck, et al.
The players are former partners in a plaintiff class action law firm that made a nice business out of hauling corporations (e.g., IBM, Pfizer, Xerox) into Madison County, Illinois. [read post]
3 Feb 2016, 4:00 am by Alan Macek
In Teva, the issue on summary trial related to the effect of a corporate merger on entitlement to remedies. [read post]
 The ETS applies to a broad range of workplaces under OSHA’s jurisdiction with a “total of at least 100 employees firm- or corporate-wide at any time the [standard] is in effect. [read post]
14 Sep 2012, 4:20 am by Max Kennerly, Esq.
Hoffman-LaRoche, Pfizer, SmithKline, and all the pharmaceutical companies had done reproductive testing routinely since the 1940s. [read post]
6 Feb 2012, 12:06 am by Kevin LaCroix
The question of the propriety of a corporate provision requiring the arbitration of shareholder claims may yet be aired at the SEC. [read post]
28 Dec 2007, 1:00 am
Senate approval: (IP Updates),Patent reform discussion in the Senate: (Patent Docs), (Washington State Patent Law Blog), Depressions, radicals, Wobblies, and patent reform: (IPBiz),Proposed patent reform and the market for ideas: (Patent Prospector),Rising claim counts: (Patently O),Counting design patents: (Patently O)District Court of Columbia dismisses suit seeking dismissal of PTO's Deputy Director, Margaret Peterlin, for lack of… [read post]
1 Jul 2010, 3:54 pm by Ilya Somin
In Kelo itself, there was a great deal of evidence that the condemnations were undertaken as a result of lobbying by the Pfizer corporation. [read post]
30 Dec 2010, 4:39 pm by Frank Pasquale
Companies such as GlaxoSmithKline have restructured and slimmed down their research arms but the sector remains troubled, as the departure of Jeff Kindler, Pfizer’s former chief executive, on the grounds of “exhaustion” indicates. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]